All In MedTech

Device Trial Radar · NCT03728985

Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

102

Actual

Start

Jun 17, 2019

Primary completion

Jan 4, 2023

Study completion Jan 2030

Sponsor

Lead sponsor
W.L.Gore & AssociatesNot on our public-company list
Sponsor type
Industry
First posted
Nov 2, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, non-randomized, , multicenter study with two independent arms: * Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System. Hypothesis-driven analysis. * Up to 65 additional subjects may be implanted in Continued Access Phase under the Primary Study Arm only * Secondary Study Arm - TAAA requiring TAMBE System and CTAG Device(s). Non hypothesis-driven analysis. Minimum: 122 implanted subjects. Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm)

Conditions

  • Thoracoabdominal Aortic Aneurysm

Interventions

  • GORE EXCLUDER Thoracoabdominal Branch EndoprosthesisDevice

    Endovascular Aortic Stent-Graft

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Subjects With Uncomplicated Technical Success and Freedom From Procedural Safety Composite EventTime frame: From start of Index Procedure to 59 Days Post Procedure
  2. Percent of Subjects Free From Clinically Significant Reintervention / Lesion-Related MortalityTime frame: 12 Months

Locations

44 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Mayo Clinic Arizona

    Scottsdale, Arizona

  • Keck Medical Center of USC

    Los Angeles, California

41 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.